Nipro Corporation operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nipro with three other
medical equipment manufacturers in Asia:
sales of 628.90 billion Japanese Yen [US$5.97 billion]
of which 56%
was Cardiovascular area business),
Asahi Intecc Co., Ltd.
(56.55 billion Japanese Yen [US$536.62 million]
of which 85%
was Medical), and
JMS Co Ltd
(58.57 billion Japanese Yen [US$555.82 million]
of which 65%
was Operating Segment-Japan).
During the year ended March of 2020, sales at
Nipro were ¥442.52 billion (US$4.20 billion).
increase of 3.8%
versus 2019, when the company's sales were ¥426.40 billion.
This was the third consecutive year of growth at Nipro.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
461.3% in 2020, from
¥31.00 million to ¥174.00 million.
Nipro also saw significant increases in sales in
Pharmaceutical Business (up 10.8% to ¥70.36 billion)